Posters and Presentations

Each year, the ARUP Institute for Clinical and Experimental Pathology® presents at more than 200 conferences, workshops, annual meetings, and symposiums for several national and international organizations. Recent posters and presentations are listed below.

Request a poster.

MARCH 2016

United States and Canadian Academy of Pathology (USCAP)
Seattle, WA, Mar 12–18, 2016

Salama ME, Patel JL, Paxton CN, Xu X, Perkins SL, Li KD—Presentation
Brown AF, Salama ME, Patel JL, Paxton CN, Xu X, Perkins SL, Li KD. Correlation between PD-L1 protein expression and 9p24.1 amplification in EBV-positive DLBCL of the eldery.

Szankasi P, Kelley TW—Poster
VanNess M, Szankasi P, Frizzell K, Shen W, Kelley TW. Analysis of ASXL1 mutations in a large series of myeloid malignancies.

Kelley TW—Poster
Wang SA, Tam W, Tsai A, Arber DA, Hasserjian RP, Geyer JT, George T, Czuchlewski DR, Foucar K, Rogers HJ, Hsi E, Rea B, Bagg A, Dal-Cin P, Kelley TW, Verstovsek S, Bueso-Ramos C, Orazi A. Targeted next-generation sequencing (NGS) of chronic eosinophilic leukemia, not otherwise specified (CEL, NOS) and of idiopathic hypereosinophilic syndrome (HES).

American College of Medical Genetics and Genomics (ACMG)
Tampa, FL, Mar 8–12, 2016

Ha Y, Morris A, Damjanovich-Colmenares K, Donahue-Wooderchak W, Sumner K, Mao R, Best DH, Bayrak-Toydemir P—Poster
Ha Y, Morris A, Damjanovich-Colmenares K, Donahue-Wooderchak W, Sumner K, Mao R, Best DH, Bayrak-Toydemir P. Retrospective analysis of the periodic fever syndrome, next-generation sequencing, and aCGH clinical assay.

Pham HT, Ha Y, Pont-Kingdon G, Lyon E—Poster
Pham HT, Ha Y, Pont-Kingdon G, Lyon E. SMN copy number determination by MLPA and digital PCR: a comprehensive approach to carrier and diagnostic testing for SMA.

Melis R, Johnson-Davis k, Paul E, McMillin G—Poster
Melis R, Johnson-Davis k, Paul E, McMillin G. Implementation of the TaqMan® OpenArray® Genotyping Platform in a clinical thiopurine s-methyltransferase (TPMT) genotype-phenotype study.

Wooderchak-Donahue W, Bayrak-Toydemir P—Poster
Wooderchak-Donahue W, Tvrdik T, Rope AF, VanSant-Webb C, Mesley R, Bull DA, Yetman AT, Plant P, Bayrak-Toydemir P. Identification of novel SMAD3 mutations in families with variable Marfan-like clinical findings featuring aortopathy.

Sumner KL, Ha Y, Paul E, Morris A, Bayrak-Toydemir P, Best HD—Poster
Sumner KL, Ha Y, Paul E, Morris A, Bayrak-Toydemir P, Elliott GC, Best HD. BMPR2 gene promoter mutation c.-669G>A is a rare finding in pulmonary arterial hypertension.

Andersen E—Presentation
Thorland E, Andersen E, Burnside R, Herriges J, Jobanputra V, Kantarci S, Kearney H, Lorentz C, Pineda-Alvarez D, Ritter D, Risheg H, Shen Y, Speevak M, Aradhya S, Riggs E, Martin CL, on behalf of the Clinical Genome (ClinGen) Resource. Dosage sensitivity curation of ACMG genes recommended for reporting of secondary findings.

McMillin G—Poster
Kamlan V and the PGx Nomenclature Workgroup. Pharmacogenetic allele nomenclature: international workgroup recommendations for test result reporting.

Procter M, Pham HT, Pont-Kingdon G, Lyon E, Rong M—Poster
Procter M, Pham HT, Pont-Kingdon G, Lyon E, Rong M. Non-NGS approach to carrier mutation panel screening for cystic fibrosis and Ashkenazi Jewish diseases.

FEBRUARY 2016

Genomics and Personalized Medicine
Banff, Canada, February 7–11, 2016

Gligorich KM, Hellwig S, Bronner M—Poster
Gligorich KM, Hellwig S, Kennedy B, Baker D, Fuertes C, Bronner M. Development of a next-generation sequencing test to detect low frequency variants in cell-free circulating tumor DNA.

Mass Spectrometry: Applications to the Clinical Laboratory (MSACL)
Palm Springs, CA, February 21–25, 2016

Kushnir MM, Rockwood AL, Strathmann FG—Poster
Kushnir MM, Tennison C, Rockwood AL, Strathmann FG. LC-MS/MS measurements of parathyroid hormone-related protein (PTHrP): negative correlation between age and PTHrP concentrations in CSF.

Clark ZD, Frank EL, Strathmann FG—Presentation
Clark ZD, Frank EL, Strathmann FG. Are we getting what we paid for with a 13C-labeled internal standard?

Rule GS, Rockwood AL – Poster Rule GS, Rockwood AL. Results from a seven month trial of single point calibration.

Smith K, Barker AP, Strathmann FG—Poster
Smith K, Barker AP, Strathmann FG. Qualitative analysis for multiple drugs in urine by liquid chromatography time of flight mass spectrometry (LC-TOF/MS).

Merrigan SD, Slawson M, Johnson-Davis KL—Poster
Merrigan SD, Slawson M, Auger S, Johnson-Davis KL. LDTD-MS/MS method for quantitative analysis of four immunosuppressant drugs in whole blood and cost analysis comparison to LC-MS/MS.

Ray JA, Kushnir MM, Strathmann FG—Presentation
Ray JA, Kushnir MM, Meikle AW, Strathmann FG. Drug stimulated endocrinopathy: impact of opiates on free hormone concentrations.

Kish-Trier E, Liu A, Erali M, and Yuzyuk T—Poster
Kish-Trier E, Liu A, Erali M, and Yuzyuk T. Quantitation of 22 long chain fatty acids by GC-NCI-MS in serum and plasma.

JANUARY 2016

American Federation for Medical Research (AFMR)
Carmel, CA, January 28–30, 2016

Martins TB, Hill HR—Poster
Martins TB, Teufel RA, Hill HR. Laboratory assays for aiding the diagnosis of chronic urticaria.

Hill HR, Martins TB, Kumanovics A—Presentation
Hill HR, Augustine NH, Miles LM, Rejali JH, Woodbury K, Pasi B, Martins TB, Kumanovics A. Effects of interferon gamma on the respiratory burst of variant x-linked chronic granulomatous disease patients versus classic x-linked dise.

DECEMBER 2015

American Society of Hematology (ASH)
Orlando, FL, Dec 5–8, 2015

Reading NS, Prchal JT, Salama M—Poster
Reading NS, Prchal JT, Hoffman R, Salama M. Digital immune expression profiling coupled with immunohistochemistry for interrogation of microenvironment of formalin-fixed paraffin-embedded specimens of marrow and spleen from the PMF patients.

Reading NS, Agarwal AM, Prchal JT—Poster
Reading NS, Clark BE, Song J, Shooter CC, Miller RE, Agarwal AM, Thein SL, Divoky V, Prchal JT. Sickle-cell anemia in a child with three β-globin clusters (β-S/β-S, β-A): loss of LCR and 3' HS1 in the duplicated wild-type β-globin cluster does not fully abrogate its transcript.

Szankasi P, Sederberg M, Schumacher JA, Patel JL, South ST, Xu X, Kelley TW—Poster
Shen W, Szankasi P, Sederberg M, Schumacher JA, Frizzell K, Gee EP, Patel JL, South ST, Xu X, Kelley TW. Targeted detection of copy number variants using a myeloid malignancy next-generation sequencing mutation panel allows comprehensive genetic analysis using a single testing method.